Afeditab CR Interactions
There are 612 drugs known to interact with Afeditab CR (nifedipine), along with 9 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 27 are major, 540 are moderate, and 45 are minor.
- View all 612 medications that may interact with Afeditab CR
- View Afeditab CR alcohol/food interactions (4)
- View Afeditab CR disease interactions (9)
Most frequently checked interactions
View interaction reports for Afeditab CR (nifedipine) and the medicines listed below.
- 5-HTP (5-hydroxytryptophan)
- Actonel (risedronate)
- albuterol
- allopurinol
- amlodipine
- Aspir 81 (aspirin)
- aspirin
- Aspirin Low Strength (aspirin)
- atenolol
- atorvastatin
- Avodart (dutasteride)
- biotin
- CoQ10 (ubiquinone)
- Diovan HCT (hydrochlorothiazide / valsartan)
- furosemide
- Ginkgo Biloba (ginkgo)
- Lipitor (atorvastatin)
- lisinopril
- losartan
- melatonin
- metformin
- metoprolol
- naproxen
- omeprazole
- pantoprazole
- Plavix (clopidogrel)
- simvastatin
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Afeditab CR alcohol/food interactions
There are 4 alcohol/food interactions with Afeditab CR (nifedipine).
Afeditab CR disease interactions
There are 9 disease interactions with Afeditab CR (nifedipine) which include:
- aortic stenosis
- cardiogenic shock/hypotension
- coronary artery disease
- liver disease
- hypertension
- myocardial infarction
- CHF/AMI
- renal dysfunction
- GI narrowing
More about Afeditab CR (nifedipine)
- Afeditab CR consumer information
- Compare alternatives
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: calcium channel blockers
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.